US OptionsDetailed Quotes
SIGA250117C5000
- 1.27
- +0.17+15.45%
15min DelayClose Jan 2 16:00 ET
1.30High0.40Low
0.40Open1.10Pre Close81 Volume66 Open Interest5.00Strike Price8.69KTurnover71.16%IV0.48%PremiumJan 17, 2025Expiry Date1.24Intrinsic Value100Multiplier15DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.9474Delta0.1192Gamma4.91Leverage Ratio-0.0037Theta0.0019Rho4.65Eff Leverage0.0014Vega
SIGA Technologies Stock Discussion
Tepoxx (Tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
Wow almost bought in too...
SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman
phew
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
SIGA Technologies (NASDAQ: SIGA) has entered into an exclusive license agreement with Vanderbilt University for a portfolio of preclinical fully human monoclonal antibodies (mAbs). These mAbs have potential as treatments for a broad range of orthopoxviruses, including smallpox and mpox. The agreement grants SIGA exclusive rights to develop, manufacture...
SIGA Technologies Inc - Contract in Response to Morocco Ministry of Health Request. Makes first commercial sale in Africa
SIGA Announces Agreement to Supply TPOXX® in Morocco
wow, finally increasing a little... wondering if it's best to wait for before earnings report to buy in
No comment yet